ライフサイエンスコーパス: fowlpox

1 ion of poultry previously vaccinated against fowlpox.

2 Recombinant avian poxviruses [fowlpox and canarypox (ALVAC)], restricted for replicati

3 previously identified homologs found in the fowlpox and canarypox viruses and the previously cloned

4 was used for priming followed by six planned fowlpox-based vector boosts.

5 howing that, as with vaccinia resolvase, the fowlpox enzyme could cleave a wide array of branched DNA

6 Recombinant poxviruses (vaccinia and fowlpox) expressing tumor-associated antigens are curren

7 pan from geographically diverse outbreaks of fowlpox in the United States were screened for the prese

8 wed by booster vaccinations with recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in 25 melanoma and 22 epi

9 me-boost malaria vaccine regimens using DNA, fowlpox or MVA, have chiefly elicited T-cell responses t

10 y assigned to receive four vaccinations with fowlpox-PSA (rF-PSA), three rF-PSA vaccines followed by

11 ns with the following: replication-defective fowlpox recombinant (rF)-CEA(6D)-TRICOM; primary vaccina

12 iciently infected by a replication-defective fowlpox recombinant vector, designated rF-TRICOM (TRIad

13 Fowlpox resolvase formed complexes with a variety of bra

14 of recombinant poxviruses [vaccinia (rV) and fowlpox (rF)] for delivery of the TAA to the immune syst

15 d by booster vaccinations with a recombinant fowlpox (rF-)-expressing LacZ (rF-LacZ) or booster vacci

16 here demonstrate: (a) A recombinant avipox (fowlpox, rF) vector expressing the signal 1 (CEA) and th

17 We report here that a recombinant avipox (fowlpox, rF) vector has been constructed that can effici

18 s, and a replication-defective avipox virus (fowlpox; rF) containing the same four transgenes (design

19 The fowlpox SECIS element supported Sec insertion when expre

20 mmunized with the recombinant viral vaccines fowlpox strain FP9 and modified virus Ankara (MVA), a pr

21 vaccinia virus Ankara (MVA), and attenuated fowlpox strain, FP9, for prime-boost vaccination approac

22 In contrast, four fowlpox vaccines of FPV origin and three originating fro

23 an rF-CEA; one administration of recombinant fowlpox vector expressing CEA and three different costim

24 tions with dendritic cells modified with the fowlpox vector rF-CEA(6D)-TRICOM.

25 Nine field strains of fowlpox virus (FPV) isolated during a 24-year span from

26 Fowlpox virus (FPV), a pathogen of poultry, can persist

27 ccines based on turkey herpesvirus (HVT) and fowlpox virus (FPV).

28 mic sequence, with analysis, of a pathogenic fowlpox virus (FPV).

29 phurae, and subsequently integrated into the fowlpox virus (FWPV) and gallid herpesvirus type 2 (GHV-

30 We show that fowlpox virus (FWPV) fails to induce chicken beta IFN (C

31 Comparison with the previously characterized fowlpox virus (FWPV) genome revealed avipoxvirus-specifi

32 We show that the prototypic avipoxvirus, fowlpox virus (FWPV), is highly resistant to the antivir

33 ied vaccinia virus Ankara (MVA) or wild-type fowlpox virus (FWPV; an avipoxvirus), and the excited-st

34 ccinia virus Ankara (rMVA) prime/recombinant fowlpox virus (rFPV) boost regimen and monkeys vaccinate

35 with either recombinant adenovirus (rAd) or fowlpox virus (rFWPV) expressing SIVmac239 or SIVmac251

36 f intratumoral administration of recombinant fowlpox virus encoding murine CD40L (rF-mCD40L) in a mur

37 st vaccine strategy using vaccinia virus and fowlpox virus expressing human prostate-specific antigen

38 To understand how fowlpox virus inhibits apoptosis, we examined FPV039 usi

39 rs, modified vaccinia virus Ankara (MVA) and fowlpox virus of the FP9 strain.

40 Here, we report that the fowlpox virus prosurvival protein FPV039 promiscuously b

41 One such viral prosurvival protein is the fowlpox virus protein FPV039, which is a potent apoptosi

42 We found that fowlpox virus resolvase was much more tractable.

43 ector with a specific attenuated recombinant fowlpox virus, FP9, vaccine in such prime-boost regimes

44 irus got inserted into another virus, called fowlpox virus, which has spread back into the wild.

45 e activity and structure of the resolvase of fowlpox virus, which provides a tractable model for in v

46 se 1 trial of modified vaccinia virus Ankara/fowlpox virus-based HIV-1 vaccines in 20 HIV-infected yo

47 otein homolog of glutathione peroxidase 4 in fowlpox virus.

48 t were infected with a helper nonreplicating fowlpox virus.

49 ne using CEA-TRICOM in a recombinant avipox (fowlpox) virus (rF-CEA-TRICOM).

50 ified vaccinia Ankara (MVA), and recombinant fowlpox were comparable in their immunogenicity.